These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29738861)

  • 1. Oxidation-induced modifications of the catalytic subunits of plasma fibrin-stabilizing factor at the different stages of its activation identified by mass spectrometry.
    Vasilyeva A; Yurina L; Indeykina M; Bychkova A; Bugrova A; Biryukova M; Kononikhin A; Nikolaev E; Rosenfeld M
    Biochim Biophys Acta Proteins Proteom; 2018 Aug; 1866(8):875-884. PubMed ID: 29738861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ozone-induced oxidative modification of plasma fibrin-stabilizing factor.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Biryukova MI; Kostanova EA
    Biochim Biophys Acta; 2013 Dec; 1834(12):2470-9. PubMed ID: 23948453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the catalytic subunit of plasma fibrin-stabilizing factor under induced oxidation.
    Vasilyeva AD; Bychkova AV; Bugrova AE; Indeykina MI; Chikunova AP; Leonova VB; Kostanova EA; Biryukova MI; Konstantinova ML; Kononikhin AS; Nikolaev EN; Rosenfeld MA
    Dokl Biochem Biophys; 2017 Jan; 472(1):40-43. PubMed ID: 28421433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
    Protopopova AD; Ramirez A; Klinov DV; Litvinov RI; Weisel JW
    J Thromb Haemost; 2019 May; 17(5):737-748. PubMed ID: 30773828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation.
    Vasilyeva A; Yurina L; Shchegolikhin A; Indeykina M; Bugrova A; Kononikhin A; Nikolaev E; Rosenfeld M
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII: novel structural and functional aspects.
    Komáromi I; Bagoly Z; Muszbek L
    J Thromb Haemost; 2011 Jan; 9(1):9-20. PubMed ID: 20880254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of factor XIII subunits.
    Katona E; Pénzes K; Csapó A; Fazakas F; Udvardy ML; Bagoly Z; Orosz ZZ; Muszbek L
    Blood; 2014 Mar; 123(11):1757-63. PubMed ID: 24408323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
    Souri M; Osaki T; Ichinose A
    J Biol Chem; 2015 May; 290(19):12027-39. PubMed ID: 25809477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nature of Resistance of the Coagulation Factor XIII Structure to Hypochlorite-Induced Oxidation.
    Vasilyeva AD; Yurina LV; Bugrova AE; Indeykina MI; Kononikhin AS; Schegolikhin AN; Ivanov VS; Nikolaev EN; Rosenfeld MA
    Dokl Biochem Biophys; 2020 Nov; 495(1):276-281. PubMed ID: 33368034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.
    Singh S; Nazabal A; Kaniyappan S; Pellequer JL; Wolberg AS; Imhof D; Oldenburg J; Biswas A
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
    Smith KA; Pease RJ; Avery CA; Brown JM; Adamson PJ; Cooke EJ; Neergaard-Petersen S; Cordell PA; Ariëns RA; Fishwick CW; Philippou H; Grant PJ
    Blood; 2013 Mar; 121(11):2117-26. PubMed ID: 23303819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
    Hettasch JM; Peoples KA; Greenberg CS
    J Biol Chem; 1997 Oct; 272(40):25149-56. PubMed ID: 9312126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests.
    Martinuzzo M; Barrera L; Altuna D; Baña FT; Bieti J; Amigo Q; D'Adamo M; López MS; Oyhamburu J; Otaso JC
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016037. PubMed ID: 27648200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.